| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |